Basket Updated
0
Items added
Immunotherapy harnesses the power of the immune system to fight immunodeficiences, autoimmune diseases, and cancer. Manipulating the immune system to attack harmful cells is an area of intense research.
Myeloid cells are differentiated from hematopoietic stem cells in the bone marrow and include monocytes, macrophages, neutrophils, basophils, eosinophils, erythrocytes, megakaryocytes, and platelets.
PD-L1/PD1 immune checkpoint helps tumor cells evade detection by the immune system. Highly specific and sensitive PD-L1 antibody now available from CST.
Immunohistochemical Analysis. Learn the best ways to interpret IHC staining and understand experimental results accurately. Click here.
Achieve high-quality immunohistochemistry staining with our specific antibodies & optimized protocols. Learn more about our IHC staining solutions.
Cell Signaling Technology, Inc. (CST) of Danvers, MA, announced today that it has introduced a highly specific PD-L1 rabbit monoclonal antibody (mAb).
Learn how to visualize protein expression in tissue with immunohistochemistry (IHC). See examples of successfully optimized IHC assays.
Cell Signaling Technology Announces the Release of a First to Market IHC-Approved VISTA Antibody
The regions recognized by our PD-1 and PD-L1 antibodies are as follows:PD-1 (EH33) Mouse mAb (IHC-Specific) #43248 binds the extracellular domain.PD-1 (D7D5W) XP® Rabbit mAb (Mouse Specific) #84651 binds the intracellular domain.PD-1 (D4W2J) XP® Rabbit mAb #86163 binds the intracellular domain.PD-L1 (E1L3N®) XP® Rabbit mAb #13684 binds the intracellular domain.PD-L1 (Extracellular Domain Specific) (E1J2J) Rabbit mAb #15165 binds the extracellular domain.PD-L1 (405.9A11) Mouse mAb #29122 binds the intracellular domain.PD-L1 (D4H1Z) Rabbit mAb #60475 binds the extracellular domain.PD-L1 (D5V3B) Rabbit mAb (Mouse Specific; IHC Specific) #64988 binds the intracellular domain.PD-L1 (Extracellular Domain Specific) (D8T4X) Rabbit mAb #86744 binds the extracellular domain.
CST and Amoy Diagnostics announced the expansion of their collaboration to use CST antibodies in companion diagnostics to aid growing oncology needs in China.
MEDx and CST announce expansion of their ongoing partnership for companion diagnostic (CDx) development using CST® antibodies to meet growing demand in China.
Multiplex IHC - Being able to visualize multiple targets simultaneously is important in research fields like immunology & oncology. Learn more here.
CST offers a growing portfolio of products for the study of immune checkpoint targets in cancer, including several receptor-ligand pairs.
Immunohistochemistry is a method for studying antigen localization in tissue sections using antibodies. Learn sample preparation, labeling, & visualization.
SignalStar™ Spatial Profiling is a revolutionary new tool for spatial biology research with fully customizable and highly-validated antibody IHC panels.
World Cancer Day raises awareness for cancer prevention, detection, and treatment. Learn about the scientific breakthroughs that are closing the care gap.
Immunofluorescence Protocol with Methanol Fixation (IF Methanol-fixed): easy to follow directions describing the step by step experimental procedure.
Flow Cytometry, Methanol Permeabilization Protocol: easy to follow directions describing the step by step experimental procedure.
Immunofluorescence Protocol with Methanol Permeabilization: easy to follow directions describing the step by step experimental procedure.
Expert-reviewed interactive pathway providing a current overview of the Inflammasome Signaling Pathway.